Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.73

+1.7%

Nov 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (3099)	11/30/2010 11:40:23 AM
From: Jibacoa	Read Replies (2) of 3722

GPRO is down for 2nd day in spite of announcing yesterday that the it has submitted a PMA to the FDA for its APTIMA HPV assay. <g> It seems the stock could come down to test support at the $50 level.<g> bigcharts.marketwatch.com GPRO has been consistently reporting better earnings for more than eight years. It has +CF, and + FCF and good institutional following. The ACTAY is $54.42 The insiders have been selling, and although the short position came down some last month, it is still about 7x the ADV.<g> It seems that with some good news the stock could get to the $60 level in spite of the PE around 24 While I was typing this note, the stock came back to yesterday's closing, apparently with the help of the DOW, which is trying to get back to the 11,000 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next